Beyond Headaches: New INFUSE Study Data Highlights...
Category : Clinical Trial Update 20 April 2026Migraine is not just a headache. It’s a full-body, brain-disrupting condition that affects how...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Nektar Therapeutics to Unveil 52-Week Data from RE...
Category : Clinical Trial Update 20 April 2026Clinical-stage biotech Nektar Therapeutics is gearing up for a key data reveal. On April 20, 2026, t...
Brenig Therapeutics Heads to AAN 2026 with Promisi...
Category : Clinical Trial Update 17 April 2026In the race to crack neurodegenerative diseases, early clinical signals matter. Brenig Therapeuti...
Apotex, Orbicular & Gland Pharma Secure Dual ANDA...
Category : Approval/Launch 17 April 2026In a market where complexity often deters competition, three companies have just executed a near tex...
GSK Bets $950M on a Next-Gen Pulmonary Hypertensio...
Category : Merger/Acquisition 16 April 2026Big pharma doesn’t spend nearly a billion dollars on a hunch. When GSK plc acquired 35Pharma I...
Latest Newsletter Post
-
Nektar Therapeutics to Unveil 52-We..
20 April 2026
-
Beyond Headaches: New INFUSE Study..
20 April 2026
-
Apotex, Orbicular & Gland Pharma Se..
17 April 2026
-
Brenig Therapeutics Heads to AAN 20..
17 April 2026
-
A New Window Into Parkinson’s Disea..
16 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com